InspireMD (NSPR) Accumulated Depreciation & Amortization (2012 - 2025)

InspireMD has reported Accumulated Depreciation & Amortization for 14 years, with the latest figure at $476.0 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 70.0% year-over-year to $476.0 million; the trailing twelve-month figure through Dec 2025 stood at $476.0 million (up 70.0% YoY), and the FY2025 full-year result was $476.0 million, up 70.0% from the prior year.
• Accumulated Depreciation & Amortization for Q4 2025 stood at $476.0 million, up from $280.0 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $476.0 million in Q4 2025, with the low at $1.7 million in Q4 2021.
• Historically, Accumulated Depreciation & Amortization has averaged $235.5 million across 5 years, with a median of $232.0 million in 2023.
• Annual changes were most pronounced in 2022 — Accumulated Depreciation & Amortization surged 10779.63% — and 2024, when it rose 20.69%.
• InspireMD's Accumulated Depreciation & Amortization stood at $1.7 million in 2021, then soared by 10779.63% to $188.0 million in 2022, then climbed by 23.4% to $232.0 million in 2023, then advanced by 20.69% to $280.0 million in 2024, then surged by 70.0% to $476.0 million in 2025.
• The last three Accumulated Depreciation & Amortization figures came in at $476.0 million (Q4 2025), $280.0 million (Q4 2024), and $232.0 million (Q4 2023), per Business Quant data.